Categories
Case studies

Standardising and scaling market access excellence across global organisations

“Access Hub has allowed us to standardise how we track and report market access across markets and regions. We now have a consistent framework, and for the first time can confidently present a single, unified view of performance to leadership.”
Global Head of Market Access Excellence and Capabilities

Client business need

A global pharmaceutical company was responsible for managing market access performance across more than 50 markets, spanning multiple regions and brands. The global access excellence team oversaw reimbursement, pricing, and KPI tracking, while coordinating data flows from regional and country teams. 

However, data was managed through a patchwork of Excel templates that varied by country and region. Reimbursement milestones, pricing data, and performance metrics were defined and tracked differently across markets, making it difficult to establish a consistent, global view. 

As a result, leadership reporting was time-consuming and error-prone. Consolidating data required manual effort from multiple teams, and differences in definitions and formats limited the ability to compare performance across markets or generate reliable insights. More importantly, the organisation lacked a consistent way to demonstrate the value and impact of market access across its global portfolio. 

Client goals 

The organisation wanted to standardise and scale how market access data was captured, governed, and reported globally. Key objectives included: 

  • Creating a single source of truth for reimbursement, pricing, and KPI data 
  • Standardising definitions and tracking of key milestones across all markets 
  • Establishing a scalable, standardised framework that could be deployed consistently across all markets, brands, and regions 
  • Reducing the manual burden of consolidating and reporting data 
  • Improving data quality, consistency, and governance 
  • Enabling faster, more reliable reporting to internal leadership and external stakeholders 

Ultimately, the goal was to move from fragmented tracking to a scalable, enterprise-wide framework that could support global decision-making and clearly demonstrate the impact of market access. 

Access Infinity response

Access Infinity implemented Access Hub as a centralised platform to standardise market access data collection, tracking, and reporting across the organisation. 

The platform introduced a unified framework for reimbursement tracking, with clearly defined milestones and statuses applied consistently across all markets. Standardised input structures ensured country teams captured data in a uniform format, eliminating inconsistencies between regions. 

 For pricing, Access Hub enabled structured tracking and comparison using consistent methodologies and exchange rates, allowing teams to analyse data on a like-for-like basis across markets. 

KPI tracking was automated through configurable dashboards, enabling teams to generate performance reports instantly without manual data manipulation. The platform’s flexibility allowed the organisation to tailor data structures to its internal processes while maintaining global consistency. 

A phased implementation approach ensured the framework was validated in key regions before scaling globally, with clear ownership established for ongoing data governance and maintenance. This created a consistent, enterprise-wide framework for market access tracking, enabling the organisation to scale standardised processes globally while maintaining governance and flexibility. 

Business impact 

  • A single, standardised source of truth across all markets, brands, and regions 
  • Significant reduction in manual data consolidation and reporting effort 
  • Improved data quality, consistency, and governance across global teams 
  • Faster, more reliable reporting to leadership and external stakeholders 
  • Enhanced ability to compare performance across markets and identify best practices 
  • Enabled leadership to clearly demonstrate the value and impact of market access through consistent, data-driven reporting 

Access Hub enabled the organisation to scale market access excellence globally, embedding a standardised framework for tracking, reporting, and demonstrating the impact of access across all markets. 

Find out more

To learn how Access Hub helps organisations standardise and scale market access tracking and reporting, head to the Access Hub landing page. 

If you would like to see it in action, book a personalised demo to explore how Access Hub can be configured to your global structure, reporting needs, and governance model. 

Categories
Case studies

HEOR: Delivering consistent, HTA-ready evidence at scale

“Evidence Hub has transformed how we work with evidence. It gives our teams confidence that they are using the right data, in the right way, at the right time, and removes a huge amount of manual effort from the process.”
Global Evidence Strategy Leader

Client business need

HEOR, medical, and market access teams at a global pharmaceutical company are responsible for different aspects of evidence management. Evidence underpinned everything from global value dossiers and SLRs to HTA submissions and lifecycle strategy. Senior evidence leaders were accountable for evidence quality, consistency, and delivery against tight submission timelines. 

However, evidence was fragmented across teams and vendors. Publications, internal analyses, and data on file were stored in multiple systems, leading to duplication of effort, version confusion, and uncertainty over which evidence was approved for use. Maintaining an up-to-date evidence base required significant manual effort, with dedicated analysts focused on tracking and summarising new publications. 

As submission deadlines approached, gaps in evidence or inconsistencies across materials were often discovered late in the process, creating rework and risk at the point when HTA readiness mattered most. 

Client goals 

The organisation wanted to strengthen governance and control over evidence generation and use. Key objectives included: 

  • Creating a single, trusted source of truth for all evidence assets 
  • Ensuring evidence was consistent, curated, and submission-ready for HTA requirements across markets 
  • Reducing duplication of work across HEOR, medical, market access teams, and vendors 
  • Improving early visibility of evidence gaps and competitive risks 
  • Freeing up senior evidence teams to focus on strategy rather than manual maintenance 

Ultimately, the goal was to deliver high-quality, HTA-ready evidence packages with greater confidence and predictability. 

Access Infinity response

Access Infinity implemented Evidence Hub as a centralised, AI-enabled platform for evidence generation, curation, and governance. 

Evidence Hub consolidated published literature, internal data on file, clinical study reports, and competitor evidence into a single, living library. Automated monitoring continuously scanned predefined databases, with quality controls ensuring accuracy and completeness. Custom taxonomies and metadata enabled teams to manage evidence according to defined standards. 

AI-powered capabilities were layered on top of the curated library, allowing users to extract insights quickly without manually reviewing hundreds of publications. Built-in guardrails ensured outputs were grounded only in approved evidence. Curation workflows, metadata control, and quality checks ensured teams worked from submission-ready content rather than ad hoc document versions. 

By serving as a shared environment for HEOR, medical, market access, and external vendors, Evidence Hub reduced handoffs and enabled faster, more coordinated evidence development. 

Business impact 

  • Greater confidence in HTA submissions through consistent, governed evidence assets 
  • Earlier identification of evidence gaps and competitive risks, reducing last-minute rework 
  • Improved coordination across HEOR teams, medical, market access, and external vendors 
  • Reduced administrative burden by automating evidence tracking and updates 
  • Faster onboarding and knowledge transfer for new team members 

Evidence Hub transformed evidence generation from a fragmented, high-risk process into a controlled, scalable capability that supported HTA success. 

Find out more

To learn how Evidence Hub helps HEOR and evidence teams deliver consistent, HTA-ready evidence at scale, visit the Evidence Hub landing page on our website. 

If you would like to see it in action, book a personalised demo to explore how Evidence Hub can support evidence generation, governance, and submission readiness across your organisation. 

Categories
Case studies

Early Market Access: Delivering fast, defensible insights for early pipeline decisions

“Nuro has completely changed how I work. I now use it for everything, from quick data checks to detailed, technical evaluations of early pipeline assets. It has become an essential part of how we assess risk and make decisions.”
Senior Director, Global Market Access

Client business need

Early access teams at a global pharmaceutical company were responsible for shaping pricing and access strategy for early pipeline assets across multiple therapeutic areas, including oncology and rare diseases. Much of their work focused on Phase 1 and Phase 2 assets, where decisions needed to be made quickly, often with limited clinical data and compressed timelines. 

Early pipeline assessments relied on fragmented processes. Teams combined internal expertise with manual research across pricing databases, public HTA assessments, external reports, and, in some cases, consultancy support. Insights were scattered across sources, making it difficult to build a consistent and defensible view of pricing potential, payer expectations, and competitive positioning. 

With limited time and resources, Market Access leaders struggled not only to move fast, but to confidently justify their assumptions and recommendations when challenged by R&D, BD, and senior governance forums. 

Client goals 

The organisation wanted to strengthen its early pipeline market access capability by: 

  • Accelerating early pricing and access assessments while ensuring assumptions were transparent, defensible, and ready for senior and BD scrutiny 
  • Rapidly identifying relevant analogues, including for orphan and rare disease assets 
  • Improving visibility into pricing assumptions, scenarios, and trade-offs 
  • Gaining earlier insight into likely payer and HTA reactions 
  • Reducing reliance on external consultancies for routine early-stage analysis 

Ultimately, the goal was to enable Market Access teams to influence decisions earlier in the asset lifecycle with credible, evidence-based insights. 

Access Infinity response

Access Infinity implemented Nuro as an integrated platform to support early pipeline pricing, access, and HTA strategy. 

Nuro enabled teams to rapidly identify and filter relevant analogues based on indication, trial design, regulatory pathway, and approval characteristics. Pricing analysis was fully transparent, allowing users to see and adjust underlying assumptions such as dosing, duration, and population characteristics to model multiple scenarios. 

The platform’s AI-powered payer insights supported early Target Product Profile (TPP) evaluation by analysing historical HTA decisions, evidence requirements, and pricing benchmarks. This allowed teams to clearly explain not just price estimates, but the rationale, risks, and trade-offs behind them when engaging with R&D, BD, and governance committees. 

In addition, Nuro provided continuously updated HTA intelligence and pipeline competitive insights, ensuring teams worked with current information when shaping early development and access strategy. 

Business impact 

  • Faster turnaround of early pipeline assessments, from days or weeks to hours 
  • Greater confidence in pricing and access recommendations through transparent, challenge-ready assumptions 
  • Earlier identification of access risks and opportunities, enabling influence before late-stage development 
  • Reduced reliance on external consultancies for routine early-stage analysis 
  • Stronger engagement with R&D and BD teams through clear, defensible strategic insights 

Market Access teams shifted from reactive research to proactive strategic leadership earlier in the pipeline. 

Find out more

To learn how Nuro helps Market Access teams deliver fast, defensible early pipeline insights, visit the Nuro landing page on our website. 

If you would like to see it in action, book a personalised demo to explore how Nuro supports early pricing, access risk assessment, and evidence strategy for pipeline and BD decisions. 

Categories
Case studies

Launch: Bringing real-time visibility to global launch progress

“Access Hub has been a gamechanger for how we track, report, and communicate market access progress during a launch. The clear visualisation and at-a-glance insights make it much easier to tell a coherent launch story to senior stakeholders, rather than just sharing static updates. The platform has genuinely changed how we work.”
Global Market Access and Launch Lead

Client business need

With a complex launch across 25+ international markets, the launch access teams were accountable for tracking regulatory, reimbursement, and access milestones, while coordinating closely with regional and country teams to support launch readiness. 

Launch tracking relied on disconnected Excel trackers, PowerPoint updates, and email-based follow-ups. Each market maintained its own version of launch data, which was periodically consolidated at global level. This created version control issues, inconsistent data, and significant manual effort. 

As launch timelines frequently shifted, leadership teams lacked a clear, up-to-date view of progress. Reporting focused on static status updates rather than a coherent picture of how access was evolving across markets. 

Client goals 

The organisation wanted to modernise its approach to launch tracking and reporting. Key objectives included: 

  • A single source of truth for launch and market access milestones 
  • Near real-time visibility across all markets 
  • Reduced manual effort chasing updates and consolidating trackers 
  • Improved data quality, consistency, and governance 
  • Clear reporting and visualisation to help leaders communicate the launch story to senior stakeholders 

Access Infinity response

Access Infinity implemented Access Hub as a centralised platform for global launch tracking, reporting, and visualisation. 

The platform consolidated regulatory, reimbursement, and market access milestones into configurable dashboards, giving global and regional teams instant visibility across all markets. A standardised framework ensured consistency, while remaining flexible enough to reflect market-specific requirements. 

Automated reminders prompted country teams to keep data current, and dashboards were actively monitored to maintain data completeness. A managed data maintenance service supported onboarding, pre-populated historical data, and produced leadership-ready reports. 

With built-in reporting and visualisation, Access Hub enabled teams to move away from static PowerPoint updates and instead communicate a clear, evolving narrative of launch progress supported by real-time data. 

Business impact 

  • Reduced manual coordination and follow-up across global and local teams 
  • Near real-time visibility into launch progress across all markets 
  • Improved confidence in leadership reporting through better data quality and governance 
  • Faster identification of risks and delays, enabling proactive decision-making 
  • Stronger leadership conversations through clear visualisation of launch progress over time 

Find out more

To learn how Access Hub can help your teams track, report, and communicate launch progress more effectively, visit the Access Hub landing page on our website. 

If you would like to see it in action, book a personalised demo to explore how Access Hub can be configured to support your launch timelines, markets, and reporting needs. 

Categories
Case studies

Launch: Removing the delays in responding to payer challenges

Client business need

A company’s HEOR team covers multiple therapeutic areas, including oncology and rare diseases. These teams manage large, complex evidence portfolios across products, indications, and markets. They support global value dossiers, HTA submissions, and ongoing payer engagement. 

Affiliates frequently needed rapid access to evidence to respond to payer questions under tight timelines. Evidence was fragmented across multiple systems and lengthy documents. This made it difficult for local teams to quickly find relevant, up-to-date information without relying on global support. 

Client goals 

The organisation wanted to modernise evidence management to better support global and local market access teams. Key objectives included: 

  • Faster, self-service access to current evidence for affiliates 
  • Reduced risk of outdated evidence in HTA submissions 
  • Improved collaboration and knowledge-sharing between countries 
  • Better usability of global value dossiers and supporting materials 
  • Less duplicated effort across markets and teams 

Access Infinity response

Access Infinity implemented Evidence Hub as a centralised, AI-powered platform for evidence management and collaboration. 

The platform automatically tracks and categorises publications across therapeutic areas and competitors. This allows users to quickly search, filter, and identify relevant evidence. Global value dossiers and key documents were uploaded with AI-driven question-and-answer functionality. Teams can extract precise insights without manually reviewing hundreds of pages. 

To enable local-to-local collaboration, the client adopted DocuHub. This is a structured workspace organised by country and product. It allows affiliates to share HTA submissions, payer feedback, and internal materials. Teams can learn from prior market experiences and avoid duplication. 

The solution was rolled out in phases across therapeutic areas. Each team configured libraries and workflows to match its specific needs and product lifecycles. 

Business impact 

  • Faster HTA responses through rapid access to validated, current evidence 
  • Reduced workload for global teams as affiliates resolve more queries independently 
  • Always-current submissions enabled by automated evidence tracking 
  • Stronger cross-country learning that improves submission quality 
  • Higher affiliate productivity through a single source of truth for evidence 

What Our Client Says

“Our affiliates can now find the right evidence quickly, stay confident it is up to date, and learn from other markets without everything flowing back to global teams. It is a real productivity accelerator for market access.”

Find out more

To learn how Evidence Hub can support your market access teams, visit accessinfinity.com/evidencehub 

If you would like to see how it works in practice, book a personalised demo to explore how the platform can be configured to your brands, teams, and workflows.